Clinical Trial Update: SK-1403 Long-term Treatment Study; Long-term Study in Patients With Secondary Hyperparathyroidism Receiving Hemodialysis [Phase 3]

View source ↗

Summary

Phase 3 long-term treatment study for secondary hyperparathyroidism in hemodialysis patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperparathyroidism

Drugs mentioned

• SK-1403

Snippet

Sponsor: Sanwa Kagaku Kenkyusho Co., Ltd. | Conditions: Secondary Hyperparathyroidism | Phase 3 | Status: COMPLETED